NCT00782639 - Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Chronic Renal ImpairmentDiabetes Mellitus

Interventions

DRUG

Iopamidol injection 76%

Iopamiro-370 (Iopamidol injection 76%) is provided in single dose bottles/vials, ready to use, aqueous, nonpyrogenic, colorless to pale yellow sterile solution

DRUG

iodixanol

Visipaque 320 (iodixanol) injection is provided in bottles/flexible containers, ready to use sterile, pyrogen-free colorless to pale yellow solution

Trial Locations (1)

08540

Bracco Diagnostics Inc., Princeton